AYA vs CGS

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

AYA

ARTRYA FPO [AYA]

54MEDIUM

CGS

COGSTATE FPO [CGS]

54MEDIUM

Score Breakdown

AYA CGS
Technical
79
61
Catalyst
50
50
Sentiment
50
50
Fundamental
82
95
Momentum
72
80
Risk Gate
50
50

Key Metrics

AYA Metric CGS
$478.6MMarket Cap$372.8M
451KAvg Volume (20d)84K
+0.8%Short Interest+0.0%
$5.24052-Week High$2.970
$0.56052-Week Low$1.210
+8.6%Daily Change+1.8%
$3.390Entry Price$2.210
-37.9%ROE+22.5%
N/AProfit Margin+19.2%

Active Signals

AYA Signals

MACD just crossed bullish — momentum is shifting to the upside
Watch out — volume is flowing out even as price holds up. Distribution pattern
On a tear — up 26.5% over the last 5 days
Beating the Small Ords index — relative strength of 1.11, so it's outpacing the pack
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (15 quarters)
Very high P/S ratio (16504.5x)

CGS Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Moderate P/S ratio (6.6x)
Moderate revenue growth (+12%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare AYA and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
AYA Full Analysis → CGS Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).